Upstream Bio Competitors and Similar CompaniesClear all
Upstream Bio's competitors and similar companies include AbClon and SUSMED.
 Upstream Bio Upstream Bio is a clinical-stage biotechnology company that develops treatments for inflammatory diseases. | |||
Founding Date | Founding Date 2021 | Founding Date 2010 | Founding Date 2015 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Waltham, US HQ | Locations KR HQ | Locations Chuo City, JP HQ |
Employees | Employees 38 | Employees N/A | Employees 39 |
Valuation ($) | Valuation ($) 1.3 b | Valuation ($) N/A | Valuation ($) 64.9 m |
Financial | |||
Revenue (est.) | Revenue (est.) $2.9m (FY, 2025) | Revenue (est.) ₩2.3b (FY, 2024) | Revenue (est.) ¥463m (FY, 2025) |
Cost of goods | Cost of goods $23m (FY, 2025) | Cost of goods (₩74.1m) (FY, 2024) | Cost of goods ¥4.3m (FY, 2025) |
Gross profit | Gross profit ($20.2m) (FY, 2025) | Gross profit ₩2.4b (FY, 2024) | Gross profit ¥458.7m (FY, 2025) |
Net income | Net income ($143.4m) (FY, 2025) | Net income (₩16.3b) (FY, 2024) | Net income (¥298.4m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
AbClon
HQ
KR
AbClon (앱클론(주)) is a developer, manufacturer, and distributor of antibody drugs.
View company
SUSMED
HQ
Chuo City, JP
Employees
39
SUSMED is a digital therapeutics (DTx) development business.
View company